|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.000 USD | -4.76% |
|
-3.85% | +45.99% |
| Market Cap | 69Cr 60Cr 56Cr 51Cr 98Cr 6.58TCr 99Cr 665.45Cr 261.32Cr 3.24TCr 259.19Cr 253.55Cr 11TCr | P/E 2026 * |
-2.85x | P/E 2027 * | -2.67x |
|---|---|---|---|---|---|
| Enterprise Value | 50Cr 44Cr 41Cr 38Cr 71Cr 4.81TCr 73Cr 486.45Cr 191.03Cr 2.37TCr 189.47Cr 185.35Cr 8.15TCr | EV / Sales 2026 * |
84,104x | EV / Sales 2027 * | 45.4x |
| Free-Float |
83.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | -4.76% | ||
| 1 week | -3.85% | ||
| Current month | -3.85% | ||
| 1 month | +5.26% | ||
| 3 months | -26.47% | ||
| 6 months | +19.76% | ||
| Current year | +45.99% |
| 1 week | 1.94 |  | 2.18 |
| 1 month | 1.9 | | 2.25 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
Franz Humer
BRD | Director/Board Member | 79 | 01/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07 | Free | Chief Executive Officer | 6,10,720 | 0.1769% | ||
| 18/06 | Free | Director | 95,400 | 0.0276% | ||
| 18/06 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.76% | -3.85% | +56.25% | -65.52% | 69Cr | |
| +1.84% | -0.66% | +59.82% | +94.48% | 5.49TCr | |
| -4.14% | -8.06% | +58.96% | +125.71% | 5.46TCr | |
| -2.24% | +3.59% | +17.75% | +469.23% | 2.51TCr | |
| -1.60% | -6.21% | -18.96% | -16.06% | 2.31TCr | |
| -1.69% | -1.38% | +39.36% | -8.40% | 1.99TCr | |
| -3.19% | 0.00% | +35.60% | -27.49% | 1.75TCr | |
| -6.84% | +2.18% | +195.12% | +364.56% | 1.65TCr | |
| -5.79% | -6.97% | +42.07% | +610.95% | 1.57TCr | |
| -1.05% | +1.16% | +25.95% | +191.69% | 1.42TCr | |
| Average | -2.95% | -0.64% | +51.19% | +173.91% | 2.42TCr | |
| Weighted average by Cap. | -2.19% | -1.46% | +50.39% | +169.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6T 5.25T 4.84T 4.47T 8.48T 6L 8.63T 57.84T 22.71T 3L 22.53T 22.04T 10L | 1.3Cr 1.13Cr 1.05Cr 96.67L 1.83Cr 123.73Cr 1.87Cr 13Cr 4.91Cr 61Cr 4.87Cr 4.77Cr 209.54Cr |
| Net income | -20Cr -17Cr -16Cr -15Cr -28Cr -1.87TCr -28Cr -189.49Cr -74Cr -923.56Cr -74Cr -72Cr -3.18TCr | -23Cr -20Cr -18Cr -17Cr -32Cr -2.17TCr -33Cr -218.96Cr -86Cr -1.07TCr -85Cr -83Cr -3.67TCr |
| Net Debt | -19Cr -16Cr -15Cr -14Cr -26Cr -1.77TCr -27Cr -179Cr -70Cr -872.43Cr -70Cr -68Cr -3TCr | -10Cr -8.82Cr -8.13Cr -7.51Cr -14Cr -961.34Cr -14Cr -97Cr -38Cr -473.59Cr -38Cr -37Cr -1.63TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $2.000 | -4.76% | 77,79,892 |
| 09/26/09 | $2.100 | -0.94% | 65,44,217 |
| 08/26/08 | $2.120 | -1.40% | 1,24,27,645 |
| 07/26/07 | $2.150 | +2.87% | 1,43,93,128 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
